To determine the inhibitory effects of niclosamide on Wnt/β-catenin signaling in human cancer cells, we examined axin2 and cyclin D1 expression in human prostate PC-3 and DU145 and breast MDA-MB-231 and T-47D cancer cells. This evidence concerns the gene AXIN2 and cancer.